Pennant Group, Inc. (PNTG) Form 10-Q — Aug 5, 2026

$PNTGForm 10-QFiled Aug 5, 2026, 4:20 PM ET0001766400-26-000065Original filing

The Pennant Group reported Q2 2026 revenue of $298.0 million, up 35.8% year over year, with net income attributable to the company of $9.1 million (vs $7.1 million) and diluted EPS of $0.25 versus $0.20 a year ago. Consolidated Adjusted EBITDA rose 48% to $24.3 million. Growth was driven largely by the $146.8 million acquisition of home health and hospice operations from UnitedHealth and Amedisys completed October 1, 2025, plus six senior living communities added in the first half of 2026.

Key figures

Eps: $0.25 diluted Q2 2026 (vs $0.20 Q2 2025); $0.49 diluted H1 2026
Revenue: Q2 2026: $297,984 thousand (vs $219,501 thousand Q2 2025); H1 2026: $583,348 thousand (vs $429,343 thousand)
Net Income: $10,898 thousand consolidated / $9,082 thousand attributable to Pennant in Q2 2026
Total Debt: $197,499 thousand ($192,499 long-term plus $5,000 current maturities) at June 30, 2026
Revenue Yoy: +35.8% (Q2 2026 vs Q2 2025)
Total Assets: $1,037,291 thousand at June 30, 2026
Cash Position: $15,273 thousand at June 30, 2026
Interest Rate: 5.88% weighted average on outstanding debt at June 30, 2026
Shares Outstanding: 34929074
Revolver availability: $145,564 thousand at June 30, 2026
Arizona subsequent event: $7,000 thousand real estate, 63 units (Aug 1, 2026)
Interest expense q2 2026: $3,348 thousand (vs $1,204 thousand Q2 2025)
Ensign leased communities: 35
Unh amedisys purchase price: $146,817 thousand (Oct 1, 2025 acquisition)
Hospice acquisition apr 2026: $2,087 thousand (April 17, 2026)
Home health admissions q2 2026: 28947
Senior living occupancy q2 2026: 78.9%
Avg hospice daily census q2 2026: 5477
Consolidated adjusted ebitda q2 2025: 16375
Consolidated adjusted ebitda q2 2026: 24267
Hartford healthcare equity investment: $28,428 thousand for 30% profit interest (June 1, 2026)
Medicare medicaid receivable concentration: 68.9% of accounts receivable
Avg monthly revenue per occupied unit q2 2026: 5392
Segment adjusted ebitdar senior living q2 2026: 15962
Segment adjusted ebitdar home health hospice q2 2026: 40951

Price after filing

1 day: 0.0%7 days: -0.6%30 days: -0.2%

Close on the filing date to close N calendar days later (from $38.61). Historical, not a forecast.

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.